QUICK READ
Neu Health has raised £1.6m in co-investment from Cedars-Sinai and Oxford Science Enterprises to expand its neurology care platform, starting with a six-month pilot at Cedars-Sinai in the U.S. The company, a University of Oxford spin-out, focuses on improving care for Parkinson’s disease and dementia through technology-driven patient monitoring and clinician support.
Founded on over a decade of Oxford research, Neu Health’s platform enables tailored care plans and proactive clinical interventions, enhancing independence and quality of life for patients. The funding will support U.S. market expansion and broader adoption of its technology, reinforcing its mission to transform global neurology care.
